Medtronic Looks Beyond The World Of Doctors And Devices In New Approach To Markets
EMEA president on the value of Swiss HQ, putting the tech into medtech and readying for the commercial challenges ahead
Health warning to global medtechs: The world’s largest medical device company is taking steps to strengthen key account management, retain its market share hold and set up new health care partnerships.
You may also be interested in...
Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care
Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.
Medtronic’s robotic-assisted surgery system earned a CE mark approval for urologic and gynecologic procedures, which make up about half of all robotic procedures.
The fragility of start-ups belies their value in medtech innovation, and they do not need unnecessary regulatory complications.